HYDROXYZINE dihydrochloride, 25mg, tab.
STD
DORAHYDX2T-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
31/07/2024, 22:00:23
Former
Code(s):
DORAZBD0213
24.3 - Medicines for anxiety disorders
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
3 - Antiallergics and medicines used in anaphylaxis
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
N05BB01
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
HYDROXYZINE dihydrochloride
- Not in the WHO list of Essential Medicines 2023
Therapeutic Action
H1-receptor antagonist antihistamine
Indications
Anxiety disorders
Instructions for use
The lowest effective dose for the shortest period of time should be prescribed.
Better option than a benzodiazepine as it is non-addictive.
The maximum dose in children (< 40kg) is 2 mg/kg.
Precautions for Use
Contraindicated in patients with prolonged QT-interval or with risk factors for QT-interval prolongation.
Administer with caution and monitor combination with:
- central nervous system depressants (opioid analgesics, sedatives, etc.)
- anticholinergic drugs (atropine, amitriptyline, chlorpromazine, promethazine, etc.)
Storage
Below 25°C ‐ Protect from sunlight ‐ Protect from humidity